Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.

Mouse sialic acid-binding immunoglobulin-like lectin F (Siglec-F) is an eosinophil surface receptor, which contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain, implicating it as a regulator of cell signaling as documented for other siglecs. Here, we show that the sialoside sequence 6'-sulfo-sLe(X) (Neu5Acalpha2-3[6-SO4] Galbeta1-4[Fucalpha1-3]GlcNAc) is a preferred ligand for Siglec-F. In glycan array analysis of 172 glycans, recombinant Siglec-F-Fc chimeras bound with the highest avidity to 6'-sulfo-sLe X. Secondary analysis showed that related structures, sialyl-Lewis X (sLe X) and 6-sulfo-sLe X containing 6-GlcNAc-SO4 showed much lower binding avidity, indicating significant contribution of 6-Gal-SO4 on Siglec-F binding to 6'-sulfo-sLe x. The lectin activity of Siglec-F on mouse eosinophils was "masked" by endogenous cis ligands and could be unmasked by treatment with sialidase. Unmasked Siglec-F mediated mouse eosinophil binding and adhesion to multivalent 6'-sulfo-sLe X structure, and these interactions were inhibited by anti-Siglec-F monoclonal antibody (mAb). Although there is no clear-cut human ortholog of Siglec-F, Siglec-8 is encoded by a paralogous gene that is expressed selectively by human eosinophils and has recently been found to recognize 6'-sulfo-sLe X. These observations suggest that mouse Siglec-F and human Siglec-8 have undergone functional convergence during evolution and implicate a role for the interaction of these siglecs with their preferred 6'-sulfo-sLe X ligand in eosinophil biology.

[1]  K. Shailubhai,et al.  Enzymatic synthesis of a 6'-sulphated sialyl-Lewisx which is an inhibitor of L-selectin binding to peripheral addressin. , 1994, Glycobiology.

[2]  M. Inaoki,et al.  CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. , 1998, Seminars in immunology.

[3]  G S Kansas,et al.  Selectins and their ligands: current concepts and controversies. , 1996, Blood.

[4]  L. Koenderman,et al.  Characterization of eosinophil adhesion to TNF-alpha-activated endothelium under flow conditions: alpha 4 integrins mediate initial attachment, and E-selectin mediates rolling. , 1999, Journal of immunology.

[5]  P. Crocker,et al.  The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophils , 2004, European journal of immunology.

[6]  M. Fukuta,et al.  Sulfation of sialyl lactosamine oligosaccharides by chondroitin 6-sulfotransferase. , 1997, Glycobiology.

[7]  K. Shailubhai,et al.  Sulfation and sialylation requirements for a glycoform of CD34, a major endothelial ligand for L-selectin in porcine peripheral lymph nodes. , 1997, Glycobiology.

[8]  N. Bovin,et al.  Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec‐7‐dependent and ‐independent mechanisms , 2003, European journal of immunology.

[9]  T. Carlos,et al.  Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. , 1991, The Journal of clinical investigation.

[10]  H. Miyazaki,et al.  Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. , 1988, The Journal of biological chemistry.

[11]  J. Marth,et al.  Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Crocker,et al.  Siglecs in the immune system , 2001, Immunology.

[13]  S. Tsuboi,et al.  6′-Sulfo Sialyl Lex but Not 6-Sulfo Sialyl Lex Expressed on the Cell Surface Supports L-selectin-mediated Adhesion* , 1996, The Journal of Biological Chemistry.

[14]  R. Kannagi,et al.  Identification of a Major Carbohydrate Capping Group of the L-selectin Ligand on High Endothelial Venules in Human Lymph Nodes as 6-Sulfo Sialyl Lewis X* , 1998, The Journal of Biological Chemistry.

[15]  M. Cybulsky,et al.  Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. , 1999, International immunology.

[16]  F. Leyva-Cobián,et al.  Eosinophil as antigen‐presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing , 1992, European journal of immunology.

[17]  A. Varki,et al.  Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. , 1999, Glycobiology.

[18]  James J. Lee,et al.  Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G). , 2003, Genomics.

[19]  R. Coffman,et al.  Depletion of eosinophils in mice through the use of antibodies specific for C‐C chemokine receptor 3 (CCR3) , 1999, Journal of leukocyte biology.

[20]  E. Shimada,et al.  Molecular Cloning and Characterization of Human Keratan Sulfate Gal-6-Sulfotransferase* , 1997, The Journal of Biological Chemistry.

[21]  T. Yamaji,et al.  A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to α2,8-Disialyl and Branched α2,6-Sialyl Residues , 2002, The Journal of Biological Chemistry.

[22]  D. King,et al.  High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker , 1992, Bio/Technology.

[23]  J. Wieruszeski,et al.  Oligosaccharide structures of mucins secreted by the human colonic cancer cell line CL.16E. , 1992, The Journal of biological chemistry.

[24]  M. Hancock,et al.  I-type lectins. , 2002 .

[25]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[26]  C. Bertozzi,et al.  L-selectin-carbohydrate interactions: relevant modifications of the Lewis x trisaccharide. , 1996, Biochemistry.

[27]  M. Kiso,et al.  L-selectin Interactions with Novel Mono- and Multisulfated Lewisx Sequences in Comparison with the Potent Ligand 3′-Sulfated Lewisa * , 1999, The Journal of Biological Chemistry.

[28]  E. Butcher,et al.  L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. , 1994, Journal of immunology.

[29]  S. Rosen,et al.  Sulphated endothelial ligands for L-selectin in lymphocyte homing and inflammation. , 2003, Biochemical Society transactions.

[30]  Ajit Varki,et al.  Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Crocker,et al.  Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. , 2002, Current opinion in structural biology.

[32]  E. Gelfand,et al.  Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. , 2004, The Journal of allergy and clinical immunology.

[33]  Jian Ni,et al.  Siglec-8 , 2000, The Journal of Biological Chemistry.

[34]  S. Hemmerich,et al.  Structure of the O-Glycans in GlyCAM-1, an Endothelial-derived Ligand for L-selectin , 1995, The Journal of Biological Chemistry.

[35]  T. Paavonen,et al.  Endothelial sulfated sialyl Lewis x glycans, putative L-selectin ligands, are preferentially expressed in bronchial asthma but not in other chronic inflammatory lung diseases. , 2000, American journal of respiratory cell and molecular biology.

[36]  T. Angata,et al.  Cloning and Characterization of a Novel Mouse Siglec, mSiglec-F , 2001, The Journal of Biological Chemistry.

[37]  B. Bochner,et al.  Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. , 2003, Blood.

[38]  J. Marth,et al.  Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22. , 2002, Glycobiology.

[39]  M. Triggiani,et al.  Secretory Phospholipases A2 Activate Selective Functions in Human Eosinophils1 , 2003, The Journal of Immunology.

[40]  T. Springer,et al.  P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. , 1997, Journal of immunology.

[41]  G. Köhler,et al.  CD22 is a negative regulator of B-cell receptor signalling , 1997, Current Biology.

[42]  S. Hemmerich,et al.  6'-sulfated sialyl Lewis x is a major capping group of GlyCAM-1. , 1994, Biochemistry.

[43]  M. Horton,et al.  Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. , 1997, Journal of immunology.

[44]  P. Weller,et al.  Lymph node trafficking and antigen presentation by endobronchial eosinophils. , 2000, The Journal of clinical investigation.

[45]  T. Tsubata,et al.  Molecular interactions regulate BCR signal inhibition by CD22 and CD72. , 2004, Trends in immunology.

[46]  Nicolai V Bovin,et al.  Glycan Array Screening Reveals a Candidate Ligand for Siglec-8* , 2005, Journal of Biological Chemistry.

[47]  James C. Paulson,et al.  Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes , 2003, Journal of Biological Chemistry.

[48]  James J. Lee,et al.  A Causative Relationship Exists Between Eosinophils and the Development of Allergic Pulmonary Pathologies in the Mouse1 , 2003, The Journal of Immunology.

[49]  P. Klenerman,et al.  Identification and Characterization of a Novel Siglec, Siglec-7, Expressed by Human Natural Killer Cells and Monocytes* , 1999, The Journal of Biological Chemistry.

[50]  M. Augustus,et al.  Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. , 1998, Blood.

[51]  R. Steinman,et al.  High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin. , 2004, International immunology.

[52]  Yuan Guo,et al.  Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR , 2004, Nature Structural &Molecular Biology.

[53]  M. Fukuta,et al.  Sulfation of sialyl N-acetyllactosamine oligosaccharides and fetuin oligosaccharides by keratan sulfate Gal-6-sulfotransferase. , 2000, Glycobiology.

[54]  M. Teixeira,et al.  Contribution of endothelial selectins and alpha 4 integrins to eosinophil trafficking in allergic and nonallergic inflammatory reactions in skin. , 1998, Journal of immunology.

[55]  A. Suzuki,et al.  Lymph node macrophages, but not spleen macrophages, express high levels of unmasked sialoadhesin: implication for the adhesive properties of macrophages in vivo. , 2002, Glycobiology.

[56]  D. Sgroi,et al.  Sialylation of the sialic acid binding lectin sialoadhesin regulates its ability to mediate cell adhesion. , 1999, Blood.

[57]  W. Fitch.  Homology a personal view on some of the problems. , 2000, Trends in genetics : TIG.

[58]  A. Varki,et al.  Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.